Jen-Sen Wu

Title: The Innovations of Jen-Sen Wu

Introduction

Jen-Sen Wu is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly with his innovative approach to drug delivery systems. His work focuses on improving the efficacy and safety of medications, which is crucial for patient care.

Latest Patents

One of Jen-Sen Wu's key inventions is a patent for a sustained release oral dosage form containing dalfampridine. This invention provides a dosage form that can be administered once daily, enhancing patient compliance. The formulation includes dalfampridine as the active pharmaceutical ingredient, along with osmotic agents in a tablet core. This sustained release oral dosage form is designed to minimize adverse effects, prevent alcohol-induced dose dumping, and maintain a consistent drug plasma concentration.

Career Highlights

Throughout his career, Jen-Sen Wu has worked with prominent companies in the biotechnology and pharmaceutical sectors. Notably, he has been associated with Pharmadax Inc. and Twi Biotechnology, Inc. His experience in these organizations has allowed him to develop and refine his innovative ideas in drug formulation.

Collaborations

Jen-Sen Wu has collaborated with talented individuals in his field, including Chih-Yao Yang and Yi-Chen Tsai. These collaborations have contributed to the advancement of his research and the successful development of his inventions.

Conclusion

Jen-Sen Wu's contributions to the field of pharmaceuticals through his innovative patent for a sustained release oral dosage form demonstrate his commitment to improving patient care. His work continues to influence the industry and pave the way for future advancements in drug delivery systems.